Gossamer Bio, Inc. Common Stock (GOSS) is a publicly traded Healthcare sector company. As of July 15, 2026, GOSS trades at $0.13 with a market cap of $70.44M and a P/E ratio of -0.54. GOSS moved -4.35% today. Year to date, GOSS is -95.48%; over the trailing twelve months it is -90.84%. Its 52-week range spans $0.11 to $3.87. Analyst consensus is neutral with an average price target of $1.09. Rallies surfaces GOSS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
4 analysts cover GOSS: 0 strong buy, 1 buy, 2 hold, 1 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $1.09.
| Metric | Value |
|---|---|
| Price | $0.13 |
| Market Cap | $70.44M |
| P/E Ratio | -0.54 |
| EPS | $-0.25 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.87 |
| 52-Week Low | $0.11 |
| Volume | 153.46K |
| Avg Volume | 0 |
| Revenue (TTM) | $114.70M |
| Net Income | $-56.53M |
| Gross Margin | 0.00% |
4 analysts cover GOSS: 0 strong buy, 1 buy, 2 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $1.09.